Scherle, Peggy
Prelude Therapeutics,
United States
2024 Rank: 252777
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1125 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 252777 | 286958 |
| Total Cites | 12553 | 13092 |
| H-index | 51 | 52 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 831 | 859 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 2980 | 3084 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10761 | 11114 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.18 |
| Self-Citation Percentage |
4.12%
|
|
Scherle, Peggy
Prelude Therapeutics,
United States
2023 Rank: 240632
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1053 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 240632 | 273529 |
| Total Cites | 11855 | 12381 |
| H-index | 49 | 50 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 819 | 847 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 2875 | 2978 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10157 | 10500 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.18 |
| Self-Citation Percentage |
4.25%
|
|
Scherle, Peggy
Incyte Research Institute,
United States
2022 Rank: 224497
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 946 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 224497 | 254757 |
| Total Cites | 11045 | 11554 |
| H-index | 48 | 49 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 808 | 836 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 2746 | 2849 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9466 | 9795 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.18 |
| Self-Citation Percentage |
4.41%
|
|
Scherle, Peggy
Prelude Therapeutics,
United States
2021 Rank: 217325
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 923 out of 88725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 217325 | 245940 |
| Total Cites | 10622 | 11129 |
| H-index | 47 | 48 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 789 | 817 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 2660 | 2764 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9116 | 9442 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.18 |
| Self-Citation Percentage |
4.56%
|
|
Scherle, Peggy
Incyte Research Institute,
United States
2020 Rank: 203116
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1086 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 203116 | 232800 |
| Total Cites | 9595 | 10068 |
| H-index | 46 | 46 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 766 | 794 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 2463 | 2563 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8256 | 8559 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
4.70%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.